KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gsk (GSK) Net Margin (2016 - 2025)

Historic Net Margin for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to 23.55%.

  • Gsk's Net Margin rose 242800.0% to 23.55% in Q3 2025 from the same period last year, while for Dec 2025 it was 21.12%, marking a year-over-year increase of 98000.0%. This contributed to the annual value of 8.21% for FY2024, which is 80400.0% down from last year.
  • As of Q3 2025, Gsk's Net Margin stood at 23.55%, which was up 242800.0% from 18.07% recorded in Q2 2025.
  • Gsk's 5-year Net Margin high stood at 138.22% for Q3 2022, and its period low was 0.72% during Q3 2024.
  • Over the past 5 years, Gsk's median Net Margin value was 18.7% (recorded in 2022), while the average stood at 23.67%.
  • In the last 5 years, Gsk's Net Margin soared by 1205900bps in 2022 and then plummeted by -1202500bps in 2023.
  • Quarter analysis of 5 years shows Gsk's Net Margin stood at 3.03% in 2021, then soared by 517bps to 18.7% in 2022, then rose by 18bps to 22.04% in 2023, then crashed by -34bps to 14.55% in 2024, then skyrocketed by 62bps to 23.55% in 2025.
  • Its Net Margin stands at 23.55% for Q3 2025, versus 18.07% for Q2 2025 and 21.61% for Q1 2025.